AR112401A1 - ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM - Google Patents

ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM

Info

Publication number
AR112401A1
AR112401A1 ARP180102214A AR112401A1 AR 112401 A1 AR112401 A1 AR 112401A1 AR P180102214 A ARP180102214 A AR P180102214A AR 112401 A1 AR112401 A1 AR 112401A1
Authority
AR
Argentina
Prior art keywords
antibodies
compositions
methods
epitopes
chimeric
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Robert Pejchal
Nels P Nielson
Seung Lee
- Rosenthal Arnon Joo
Helen Lam
Patricia Culp
Original Assignee
Alector Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alector Llc filed Critical Alector Llc
Publication of AR112401A1 publication Critical patent/AR112401A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente descripción hace referencia, en líneas generales, a composiciones que incluyen anticuerpos, por ejemplo, anticuerpos monoclonales, quiméricos, humanizados, fragmentos de anticuerpos, etc., que se unen específicamente a uno o más epítopos de una proteína CD33, por ejemplo, CD33 humana o CD33 de mamífero y tienen características funcionales mejoradas y/o potenciadas, y al uso de dichas composiciones para prevenir, reducir el riesgo y tratar a un individuo que lo necesite.The present disclosure refers, broadly, to compositions that include antibodies, for example, monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind to one or more epitopes of a CD33 protein, for example, Human CD33 or mammalian CD33 and have improved and / or enhanced functional characteristics, and the use of said compositions to prevent, reduce the risk and treat an individual in need.

ARP180102214 2017-08-03 2018-08-03 ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM AR112401A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762541024P 2017-08-03 2017-08-03

Publications (1)

Publication Number Publication Date
AR112401A1 true AR112401A1 (en) 2019-10-23

Family

ID=68382541

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180102214 AR112401A1 (en) 2017-08-03 2018-08-03 ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM

Country Status (1)

Country Link
AR (1) AR112401A1 (en)

Similar Documents

Publication Publication Date Title
ECSP19078414A (en) ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM
CR20230170A (en) Anti-trem2 antibodies and methods of use thereof
MX2017012802A (en) ANTISORTILINE ANTIBODIES AND METHODS FOR USE.
ECSP21010450A (en) ANTI-SORTILINA ANTIBODIES AND METHODS FOR THEIR USE
HK1252675A1 (en) Anti-cd33 antibodies and methods of use thereof
WO2016201388A3 (en) Anti-cd33 antibodies and methods of use thereof
ECSP20082648A (en) ANTI-SIRPA ANTIBODIES AND METHODS OF USING THEM
WO2017075432A3 (en) Anti-siglec-9 antibodies and methods of use thereof
MX2021002299A (en) ANTI-CD33 ANTIBODIES AND METHODS FOR USING THEM.
AR100680A1 (en) ANTI-DR5 ANTIBODIES AND MOLECULES THAT INCLUDE DR5 JOINT DOMAINS OF THE SAME
EA202190183A1 (en) ANTIBODIES TO SIGLEC-5 AND METHODS OF THEIR APPLICATION
MX2021015212A (en) ANTISORTILINE ANTIBODIES FOR USE IN THERAPY.
MX2020013172A (en) Anti-siglec-7 antibodies and methods of use thereof.
MX2024010324A (en) Methods of use of anti-trem2 antibodies.
AR112401A1 (en) ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM
AR122237A1 (en) ANTI-SORTILINA ANTIBODIES AND METHODS FOR THEIR USE
EA201992319A1 (en) ANTI-CD33 ANTIBODIES AND WAYS OF THEIR APPLICATION
AR100523A1 (en) MAPPING OF EPITOPES OF THE HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C AND ITS BACKGROUND USES

Legal Events

Date Code Title Description
FA Abandonment or withdrawal